Nonbiologic Injections in Sports Medicine.

JBJS Rev · Feb 2020 · Review

Bedi A, Trinh TQ, Olszewski AM, Maerz T, Ramme AJ

Department of Orthopaedic Surgery, University of Michigan, Ann Arbor

Sports Medicine

SUMMARY — THE REDUCTIONReviews mechanisms, benefits, and risks—including tissue toxicity—of nonbiologic injections (anesthetics, corticosteroids, NSAIDs) commonly used for analgesia in athletes.
Abstract, as published

Nonbiologic medications (local anesthetics, corticosteroids, and nonsteroidal anti-inflammatory drugs) are commonly administered to athletes for analgesia after injury. However, the risks of nonbiologic injections often are overlooked simply because of their long-term market availability. A thorough understanding of the mechanism of action, the reported benefits, and the potential risks of nonbiologic medications is crucial prior to their use, especially in the treatment of young athletes. Sports medicine physicians and surgeons must be aware of the systemic and local effects of these medications to ensure an appropriate drug choice that minimizes side effects and avoids recently reported toxicity to myocytes, tenocytes, and chondrocytes.

Featured in the 2026-09-05 issue.

← Quadriceps Tendon Autograft in Anterior Cruciate Ligament Rec…Management after acute injury of the anterior cruciate ligame… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.